InvestorsHub Logo
Followers 7
Posts 2184
Boards Moderated 0
Alias Born 12/20/2017

Re: Money $hot post# 5302

Wednesday, 03/20/2019 10:19:05 AM

Wednesday, March 20, 2019 10:19:05 AM

Post# of 16696
Sister company no closer to commercialization...than ALGERNON...???


It's simply unreasonable to have breathalyzer technology valued as much as 30 times more by our sister company which is no closer to commercialization than Algernon.



I beg to differ.

BLOZF has been targeting THC compounds....PERIOD. By refining, refining and more refining the process...BLOZF has become closer and closer to the finish line.

BTHCF keeps changing the direction of target breath compounds.....EACH time BTHCF changes breath target compounds...we go back to square one. Each time BTHCF goes back to square one, while BLOZF keeps refining its breathalyzer....the valuation between the two companies widens...as expected by most people. So...Its simply unreasonable to believe otherwise.


Nor is there any definitive comparison to how big either market cap is ultimately.



I agree...both markets are immense. If BTHCF could maintain direction and focus with the breathalyzer development...we could tap that market.


So all things being equal...it's simply the Hype Of The Story (USD300M) that has always separated the two in terms of valuation.



All things are NOT equal.....BLOZF is in manufacturing and field testing....and therefore...very close to the finish line........meanwhile BTHCF keeps starting over with breath target compounds.


A Love/Hate relationship. Breathtec's story was never really told and suffered a slow and painful exit. Enter Algernon Pharmaceuticals. A New Story with a lot to be hyped about.



The ALGERNON story is a poor substitute for a breathalyzer. I think targeting big Pharma to partner with medical breathalyzer development...would be a story worth hearing...and investing in...and bring back the pothead investors, and also the non pothead investors.

GLTA

GO FOR THE BREATHALYZER ALGERNON...GO BLOZF...LIHT THE WAY